CJC-1295 With DAC

Overview
CJC-1295 (With DAC) is a GHRH (growth hormone–releasing hormone) analog that includes a Drug Affinity Complex (DAC)—an albumin-binding motif designed to extend circulating time. It’s commonly used in controlled studies that compare sustained GH/IGF-1 exposure to shorter, pulse-style approaches. We keep things straightforward: clean labeling, clarity-first specs, and access to batch documentation so you can verify exactly what you’re working with.

Key research highlights (in plain terms)

• Extended profile via DAC — the DAC component promotes albumin association, supporting longer exposure in models that track GH/IGF-axis signals over time.

• Endocrine cascade mapping — used to examine how extended GHRH-receptor activation influences downstream markers (e.g., IGF-1 panels and related readouts).

• Comparative pharmacology — useful for side-by-side studies versus CJC-1295 (No DAC/Mod GRF 1-29) to contrast half-life, exposure curves, and response dynamics.

• Combination models — often paired in research with ghrelin-pathway agonists (e.g., Ipamorelin) to explore additive or synergistic effects on GH patterns under controlled conditions.

Why Pegasus

• Purity you can verify: batch testing with documentation (COA available)

• Clarity in every vial: straightforward specs and labeling

• Consistency you can trust: stable sourcing and careful handling

Specifications

• Form: Lyophilized powder

• Identity: GHRH analog with Drug Affinity Complex (DAC)

• Appearance: White to off-white

• Purity: ≥98% (HPLC)

• Solubility: Sterile water or appropriate buffer (optimize per protocol)

• Packaging: Labeled vial with lot and batch ID

Storage & handling

• Store dry at −20 °C, protected from light and moisture

• After reconstitution, aliquot and store at −20 °C; avoid repeated freeze–thaw cycles

Included with your order

• Labeled vial of CJC-1295 (With DAC) (research grade)

• Batch/lot ID with access to testing details (COA)